Decoding DNA Damage Response (DDR) Efficacy in Tumour Models to Advance Translation into the Clinic

Time: 9:20 am
day: Conference Day Two


• Identifying current challenges associated with evaluating DDR-targeted therapies in preclinical tumour models

• Uncovering assays to assess the effects of polymerase theta in combination therapy

• Exploring strategies to improve the translational relevance of DDR studies